Press Releases June 15, 2026 04:01 PM

CVB Financial Corp. Announces Authorization of 15 Million Share Repurchase Plan

CVB Financial Corp. authorizes a $15 million share repurchase program reflecting strong capital and earnings performance.

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
CVBF

CVB Financial Corp. announced that its Board of Directors has authorized a repurchase program to buy back up to 15 million shares of its common stock, replacing the previous share repurchase program. This move signals confidence in the company's robust capital position and its ability to generate quality earnings, aiming to deliver long-term value to shareholders.

CVB Financial Corp. Announces Authorization of 15 Million Share Repurchase Plan
CVBF
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Board authorized a share repurchase plan to buy up to 15 million shares of common stock.
  • The new repurchase plan replaces the previous 2024 program, under which over 5.6 million shares were still available for buyback.
  • CVB Financial Corp. is among the top ten bank holding companies headquartered in California, with over $20 billion in total assets following recent mergers.

Ontario, CA, June 15, 2026 (GLOBE NEWSWIRE) -- CVB Financial Corp. (NASDAQ: CVBF) announced that at a meeting on June 15, 2026, the Board of Directors of CVB Financial Corp. (the “Company”), the holding company for Citizens Business Bank, National Association, authorized the Company to repurchase up to 15,000,000 shares of the Company’s common stock (the “2026 Repurchase Program”), including by means of one or more Rule 10b5-1 plans or other appropriate buy-back arrangements, including open market purchases and private transactions.

“The approval of this share repurchase program reflects our robust capital position, consistent track record of producing quality earnings, and history of delivering long term value to our shareholders,” said David A. Brager, Chief Executive Officer.

This 2026 Repurchase Program replaces in its entirety the Company’s previous 2024 share repurchase program under which 5,678,223 shares remained available for repurchase.

Corporate Overview
CVB Financial Corp. (“CVBF”) is the holding company for Citizens Business Bank, National Association. CVBF is one of the ten largest bank holding companies headquartered in California with more than $20 billion in total assets as of the closing of the mergers with Heritage Commerce Corp and its principal banking subsidiary, Heritage Bank of Commerce. Citizens Business Bank, National Association, is consistently recognized as one of the top performing banks in the nation and offers a wide array of banking, lending and investing services, with more than 75 banking centers and three trust office locations serving California.

Shares of CVB Financial Corp. common stock are listed on the NASDAQ under the ticker symbol “CVBF”. For investor information on CVB Financial Corp., visit our Citizens Business Bank website at www.cbbank.com and click on the “Investors” tab.

Contact: David A. Brager
Chief Executive Officer
(909) 980-4030


Risks

  • Future share price volatility may impact the effectiveness of the repurchase program.
  • Economic and banking sector conditions could affect the company's capital position and ability to continue buybacks.
  • Regulatory changes or restrictions on share repurchases in the banking industry may limit program execution.

More from Press Releases

Canadian Businesses Carrying More Debt As Tariffs and Payment Stress Deepens Sep 14, 2026 Zoom Got It Done: Company’s New Ad Campaign Featuring Kate McKinnon Shows How Zoom Turns Conversations into Completed Work Sep 14, 2026 The Elmet Group to Deploy Strategic Capital to Strengthen U.S. and Allied Tungsten Supply Chain Sep 14, 2026 Department of War Makes Landmark $450 Million Committed Investment in The Elmet Group to Secure America’s Tungsten Supply Chain Sep 14, 2026 BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients Sep 14, 2026